Related Experiment Video
Updated: Mar 31, 2026
08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
13.4K
Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy
Yolanda González-Fernández, Edurne Imbuluzqueta, Ana Patiño-García
1Department of Pharmacy and Pharmaceutical Technology, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain. mjblanco@unav.es.
Current Pharmaceutical Design
|October 28, 2015
Summary
Nanotechnology offers a promising approach to enhance osteosarcoma treatment by developing targeted lipid nanocarriers. These carriers improve drug delivery to bone tumors, reducing toxicity and overcoming resistance for better patient outcomes.
Area of Science:
- Oncology
- Nanomedicine
- Biotechnology
Background:
- Osteosarcoma is a primary bone cancer in children with poor prognosis due to metastasis.
- Current treatments face challenges like poor drug penetration, toxicity, and multidrug resistance.
Purpose of the Study:
- To review lipid nanocarriers for delivering anti-osteosarcoma drugs.
- To discuss the potential of nanocarriers in treating osteosarcoma.
Main Methods:
- Literature review of nanotechnology applications in osteosarcoma therapy.
- Analysis of lipid nanocarrier systems for drug delivery.
Main Results:
- Lipid nanocarriers can target drugs to osteosarcoma cells, increasing concentration in tumors.
- Nanocarriers reduce systemic drug exposure and toxicity.
- They show potential in overcoming multidrug resistance.
Conclusions:
- Lipid nanocarriers represent a significant advancement in osteosarcoma treatment strategies.
- Targeted delivery via nanocarriers can improve efficacy and reduce side effects of chemotherapy.
